tiprankstipranks
Sanofi (FR:SAN)
:SAN
France Market
SAN
Sanofi
RESEARCH TOOLSreports

Sanofi (SAN) Stock News & Sentiment

305 Followers
Balanced Risk-Reward Amid Promising Lunsekimig Data and Valuation Uncertainty Supports Hold Rating
Premium
Ratings
Balanced Risk-Reward Amid Promising Lunsekimig Data and Valuation Uncertainty Supports Hold Rating
5d ago
SNY
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
Premium
Company Announcements
Sanofi’s Amlitelimab Eczema Trial Reaches Completion, Setting Up a Key Pipeline Catalyst
25d ago
SNYNF
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
Premium
Company Announcements
Sanofi’s Lunsekimig Asthma Study Completion: What Investors Should Watch Next
27d ago
SNYNF
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
Premium
Company Announcements
Regeneron and Sanofi Complete Key Dupilumab Pregnancy Safety Study With Fresh Data Update
1M ago
REGN
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
Premium
Company Announcements
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
2M ago
REGN
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
Premium
Ratings
Sanofi: De‑Risked Earnings and Robust Medium‑Term Growth Overlooked by Discounted Valuation
2M ago
SNY
Is SNYNF a Buy, Before Earnings?
Premium
Pre-Earnings
Is SNYNF a Buy, Before Earnings?
3M ago
More FR:SAN News >

SAN News on the Web

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sanofi (OtherSNYNF)
TipRanks News
Neutral
Sanofi becomes market authorization holder for Nuvaxovid in Canada
TipRanks News
Neutral
Dianthus initiated with an Outperform at Wolfe Research
TipRanks News
Neutral
Balanced Risk-Reward Amid Promising Lunsekimig Data and Valuation Uncertainty Supports Hold Rating
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: NovaBridge Biosciences (NBP) and Sanofi (OtherSNYNF)
TipRanks News
Bullish
Sanofi's Lunsekimig Shows Promise In Respiratory Diseases
rttnews
Bullish
Analysts Offer Insights on Healthcare Companies: Enlivex (ENLV) and Sanofi (OtherSNYNF)
TipRanks News
Neutral
Sanofi: Lunsekimig Meets Primary, Key Secondary Endpoints In Phase 2 Respiratory Studies
rttnews
Bullish

News Score - Last 7 Days

Very Positive
FR:SAN
Sector Average
Media Buzz
This Week8 articles
Weekly Average11 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:SAN’s Media Buzz Sentiment?
8 articles about FR:SAN were published this week. In an average week, 11 articles are published.
    What is FR:SAN’s weekly average amount of articles?
    In an average week, 11 articles about FR:SAN are published.
      What is FR:SAN’s News Sentiment?
      100% of articles about FR:SAN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week